Limited utility of Plasma Elafin as a biomarker for Skin Graft Versus Host Disease following allogeneic stem cell transplantation.
George L, Mahabal G, Mohanan E, Balasubramanian P, Peter D, Pulimood S, Lakshmi K, Jeyaseelan L, Abraham A, Srivastava A, et al. Limited utility of Plasma Elafin as a biomarker for Skin Graft Versus Host Disease following allogeneic stem cell transplantation. Clin Exp Dermatol. 2021.